Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 10,159 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Europe | 10,159 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 306,670 |
| Germany | 73,127 |
| France | 73,097 |
| Italy | 48,361 |
| China | 45,791 |
| Japan | 38,701 |
| Spain | 36,382 |
| United Kingdom | 32,384 |
Trial sites
10,159 sites. Sites with a public page link to it on Pharma Observatory.
-
Investigational Site Number : 2080001 12 trials
-
Novartis Investigative Site 12 trials
-
Novartis Investigative Site 12 trials
-
Novo Nordisk Investigational Site 12 trials
-
Research Site 12 trials
-
Research Site 12 trials
-
Svendborg Sygehus 12 trials
-
Aarhus Universitets Hospital 11 trials
-
Aarhus University Hospital, Skejby 11 trials
-
CCBR Vejle 11 trials
-
GSK Investigational Site 11 trials
-
GSK Investigational Site 11 trials
-
Herlev Hospital 11 trials
-
Herlev-Gentofte Hospital 11 trials
-
Juliane Marie Center, Rigshospitalet 11 trials
-
Mental Health Centre Copenhagen 11 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.